Patent Application
20240042144
The present disclosure relates to a mouthpiece for an inhaler article and to inhaler articles comprising the mouthpiece. Specifically, the present invention relates to a mouthpiece for powder inhalers.
Dry powder inhalers used to dispense powdered medicaments often strive to provide an entire dry powder dose in a single dose. Such dry powder inhalers are often complex in their design and may involve moving parts. In addition, these complex dry powder inhalers are difficult to produce and assemble at high speeds.
Dry powder inhalers that are constructed to provide dry powder particles to the lungs at inhalation (air flow) rates that are within conventional smoking regime inhalation (air flow) rates may be designed with linear airflow paths between the powder receptacle and the outlet. Dry powder inhalers may contain inhalable powder in a capsule that may be pierced to access the powder. However, loose powder may sometimes unintentionally fall out of such inhalers if the inhaler is inverted or otherwise manipulated in a non-upright position.
It is desirable to provide a mouthpiece for an inhaler article that mitigates unintentional powder leakage from the inhaler article. It is desirable to provide a mouthpiece for an inhaler article that captures loose powder within the inhaler in the event that the inhaler is turned upside down. It is desirable to provide a mouthpiece for an inhaler article that allows powder to be inhaled at inhalation (air flow) rates that are within conventional smoking regime inhalation (air flow) rates. It is desirable to provide a mouthpiece having a simple design that is easy to manufacture and an inhaler article that is easy to assemble.
All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein and are not meant to limit the scope of the present disclosure.
The term “substantially” as used here has the same meaning as “significantly,” and can be understood to modify the term that follows by at least about 90%, at least about 95%, or at least about 98%.
The term “not substantially” as used here has the same meaning as “not significantly,” and can be understood to have the inverse meaning of “substantially,” i.e., modifying the term that follows by not more than 25%, not more than 10%, not more than 5%, or not more than 2%.
For the purpose of the present description and of the appended claims, except where otherwise indicated, all numbers expressing amounts, quantities, percentages, and so forth, are to be understood as being modified in all instances by the term “about.” Also, all ranges include the maximum and minimum points disclosed and include any intermediate ranges therein, which may or may not be specifically enumerated herein. In this context, therefore, a number A is understood as A±5% of A. Within this context, a number A may be considered to include numerical values that are within general standard error for the measurement of the property that the number A modifies. The number A, in some instances as used in the appended claims, may deviate by the percentages enumerated above provided that the amount by which A deviates does not materially affect the basic and novel characteristic(s) of the claimed invention. Also, all ranges include the maximum and minimum points disclosed and include any intermediate ranges therein, which may or may not be specifically enumerated herein.
Terms such as “a,” “an,” and “the” are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration.
The terms “a,” “an,” and “the” are used interchangeably with the term “at least one.” The phrases “at least one of” and “comprises at least one of” followed by a list refers to any one of the items in the list and any combination of two or more items in the list.
As used here, the term “or” is generally employed in its usual sense including “and/or” unless the content clearly dictates otherwise. The term “and/or” means one or all of the listed elements or a combination of any two or more of the listed elements.
As used here, “have”, “having”, “include”, “including”, “comprise”, “comprising” or the like are used in their open-ended sense, and generally mean “including, but not limited to.” It will be understood that “consisting essentially of,” “consisting of,” and the like are subsumed in “comprising” and the like. As used herein, “consisting essentially of,” as it relates to a composition, product, method or the like, means that the components of the composition, product, method or the like are limited to the enumerated components and any other components that do not materially affect the basic and novel characteristic(s) of the composition, product, method or the like.
The words “preferred” and “preferably” refer to embodiments that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the disclosure, including the claims.
In the present disclosure, an inhaler article is provided that is suitable for inhaling a dry powder. The inhaler article generally includes an inhaler body and a mouthpiece element coupled with the inhaler body. The inhaler body includes a receptacle for housing an inhalable powder. An airflow path is provided through the mouthpiece element.
In some embodiments, the inhaler article may be used with a holder. For example, the inhaler article may be configured for use with a holder that is capable of opening a closed distal end of the inhaler article. The inhaler article may be configured for use with a holder that is capable of piercing a dry powder capsule housed in the receptacle. The inhaler article may be configured for use with a holder that provides an air inlet for the inhaler article.
According to embodiments, the mouthpiece element mitigates unintentional powder leakage from the inhaler article. The mouthpiece element is constructed to reduce or prevent loose powder from falling out of the inhaler article in the event that the inhaler article is turned upside down. The mouthpiece element allows powder to be inhaled at inhalation (air flow) rates that are within conventional smoking regime inhalation (air flow) rates, such as 5 L/min or less, or 2 L/min or less. The mouthpiece element has a simple design that is easy to manufacture. The mouthpiece element and inhaler article are easy to assemble.
According to an aspect of the present invention, there is provided an inhaler article comprising an inhaler body comprising a tubular side wall defining an interior and a longitudinal center axis. The interior forms a receptacle for housing an inhalable powder. The inhaler article further comprises a mouthpiece element extending along the longitudinal center axis from a distal end to a proximal end. “Proximal” means the end to be accessed by the mouth of a user when in use. “Distal” means the end opposite the proximal end when in use. The distal end of the mouthpiece element is received in the interior of the inhaler body. The mouthpiece element comprises a tube extending coaxially with the inhaler body. The tube comprises an interior surface having a first diameter. The mouthpiece element comprises a blocker disposed at the distal end of the mouthpiece element, coaxial with the tube. The mouthpiece element comprises a collector surface. The mouthpiece element comprises an airflow channel extending through the mouthpiece element. The airflow channel comprises an off-set portion extending from the receptacle to the collector surface, and a discharge portion extending to an outlet at the proximal end of the mouthpiece element. The off-set portion is substantially parallel to and laterally off-set from the discharge portion.
According to an embodiment, the inhaler article of the present disclosure mitigates unintentional powder leakage from the inhaler article. The inhaler article includes one or more features that capture loose powder within the inhaler in the event that the inhaler is turned upside down. According to an embodiment, the inhaler article of the present disclosure comprises a mouthpiece with a blocker and a collector surface that are arranged such that the amount of powder inadvertently falling out of the inhaler is reduced or minimized when the inhaler is inverted. The collector surface is configured to collect or capture any loose powder inside the inhaler. The collector surface prevents or reduces the amount of powder falling out of the receptacle when the inhaler is inverted. According to an embodiment, the inhaler article of the present disclosure comprises a mouthpiece that has an off-set portion in the airflow channel and a collector surface where powder is collected. By providing a blocker and an airflow channel with an off-set portion (for example, a non-linear airflow channel), loose powder does not simply fall out of the receptacle through the airflow channel. Due to the design of the mouthpiece, any loose powder collected or captured on the collector surface may be dropped back into the receptacle by turning the inhaler upright. Alternatively, the inhaler article and mouthpiece may be cleaned by turning the inhaler article upside down and tapping the inhaler article against a surface (for example, a table). The inhaler article may be tapped several times to cause loose powder to fall out.
The inhaler article of the present disclosure allows powder to be inhaled at inhalation (air flow) rates that are within conventional smoking regime inhalation (air flow) rates. The inhaler body and the mouthpiece have a simple design that is easy to manufacture and easy to assemble into an inhaler article. According to an embodiment, the mouthpiece may be simply inserted into a tubular inhaler body.
According to an embodiment, the discharge portion of the mouthpiece airflow channel is parallel to the longitudinal center axis. The discharge portion may be coaxial with the longitudinal center axis. According to an embodiment, the off-set portion of the mouthpiece airflow channel is parallel to the longitudinal center axis. The off-set portion may be coaxial with the longitudinal center axis. In some embodiments, both the discharge portion and the off-set portion are parallel to or coaxial with the longitudinal center axis, while being laterally off-set from one another. According to an embodiment, the inhaler article does not include an airflow path extending linearly from the receptacle to the outlet. The airflow channel may comprise an intermediate portion connecting the off-set portion and the discharge portion. The intermediate portion may extend radially inward from the off-set portion.
The collector surface is a surface of the mouthpiece that is constructed and configured to stop and/or capture loose particles inside the inhaler article when the inhaler article is turned from an upright position. An upright position in this context is considered to be the position where the proximal end and the mouthpiece of the inhaler article are pointing upward. For example, when the inhaler article is turned 90 degrees or more (for example, from 135 to 180 degrees) from the upright position, the collector surface may capture loose particles that may fall from the receptacle toward the proximal end. The collector surface may form a ring. For example, the collector surface may form a ring around a portion of the airflow channel. According to an embodiment, the inner diameter of the collector ring is greater than the first diameter (that is, the inner diameter of the tube). The outer diameter of the collector ring is greater than the second diameter (that is, the diameter of the blocker).
According to an embodiment, the mouthpiece element comprises a blocker disposed at the distal end of the mouthpiece element. The blocker may be arranged to block airflow through the center of the mouthpiece element at the distal end of the mouthpiece element.
According to an embodiment, the tube defines an outlet at the proximal end of the mouthpiece element. The proximal end of the mouthpiece element may be the mouth end of the inhaler article. The distal end of the mouthpiece element is inserted into or disposed inside the inhaler body. In some embodiments, a portion of the mouthpiece element is disposed inside the inhaler body. A portion of the mouthpiece element (for example, the mouth end) may be outside of the inhaler body. In one embodiment, a majority of or the entire mouthpiece element is disposed inside the inhaler body. The distal end of the mouthpiece element may form a proximal end of the receptacle. The receptacle may extend from the distal end of the inhaler body to the distal end of the mouthpiece element. The inhaler body may have a closed distal end. The distal end of the inhaler body may have a folded closure. For example, the distal end of the inhaler body may be folded closed by a fan fold. The distal end of the inhaler body may form the distal end of the receptacle.
According to an embodiment, the receptacle is constructed to receive a capsule containing inhalable powder. In some embodiments, the receptacle comprises a capsule containing inhalable powder. The inhaler article may be suitable for inhalation and delivery of various different inhalable powders. According to an embodiment, the capsule contains dry powder comprising particles containing one or more pharmaceutically active agents. Examples of pharmaceutically active agents include nicotine, anatabine, antiviral compounds such as acyclovir; anti-inflammatory compounds such as salicylic acid, aceclofenac, or ketoprofen; antidiabetic compounds such as metformin or glipizide; antihypertensive compounds such as oxprenolol; antiemetic compounds such as promethazine; antidepressant compounds such as seproxetine; anticoagulant compounds such as picotamide; bronchodilators such as clenbuterol; or anticancer compounds such as beta-lapachone. The pharmaceutically active agent may include a pharmaceutically acceptable salt of the pharmaceutically active agent. Suitable salts include, for example, a salt of lactic acid (“lactate”), tartaric acid (“tartrate” or “bitartrate”), aspartic acid (“aspartate”), pyruvic acid (“pyruvate”), citric acid (“citrate”), salicylic acid (“salicylate”), glutamic acid (“glutamate”), gentisic acid (“gentisate”), benzoic acid (“benzoate”), fumaric acid (“fumarate”), hydrochloric acid (“hydrochlorate”), alfa-resorcylic acid (“alfa-resorcylate”), beta-resorcylic acid (“beta-resorcylate”), oxalic acid (“oxalate”), p-anisic acid (“anisate”), glutaric acid (“glutarate”), and the like. In some cases, the capsule contains nicotine powder. For example, the capsule may contain a dry powder comprising nicotine salt. The dry powder may further contain other components, such as sugar or sugar alcohol, amino acid, flavorant, cough suppressant, or other pharmaceutically acceptable ingredients that are suitable for use in inhalable powders. In one embodiment, the capsule contains nicotine powder comprising nicotine particles, where the nicotine particles comprise nicotine salt, sugar or sugar alcohol, and amino acid. The capsule may further comprise flavor particles, cough suppressant particles, or both flavor and cough suppressant particles. Flavor and cough suppressant particles are collectively referred to here as flavor particles. The capsule may contain an inhalable powder comprising pharmaceutically active agent particles with MMAD particle size in the range of 0.5 μm to 10 μm, or 0.5 μm to 5 μm. In one embodiment, the capsule contains nicotine powder comprising nicotine particles, where the nicotine particles have MMAD particle size in the range of 0.5 μm to 10 μm, or 0.5 μm to 5 μm. The capsule may further contain flavor particles having MMAD particle size of 10 μm or greater, 20 μm or greater, or 40 μm or greater. The flavor particles may have MMAD particle size of 200 μm or less, 150 μm or less, or 120 μm or less. The flavor particles may have MMAD particle size of 20 μm to 200 μm or from 40 μm to 120 μm. In some embodiments, the capsule contains nicotine particles having MMAD particle size in the range of 0.5 μm to 10 μm, or 0.5 μm to 5 μm and flavor particles having MMAD particle size of 20 μm to 200 μm or from 50 μm to 150 μm. In a preferred embodiment, the capsule contains nicotine powder.
The inhaler body and the mouthpiece element may be constructed of any suitable materials. In some embodiments, the mouthpiece element is constructed of injectable, extrudable, or moldable polymeric material. In a preferred embodiment, the mouthpiece element is constructed of injectable polymeric material. Any suitable polymer may be used. In a preferred embodiment, the mouthpiece element is made of injection molded bioplastic. A bioplastic may be a polymer that is made from biobased ingredients or is biodegradable, or that is both made from biobased ingredients and is biodegradable. Biobased ingredients may be evaluated based on European standard CEN/TS 16137:2011. Biodegradability may be determined based on European standard EN13432.
The inhaler body may be constructed of one or more of paper, paperboard, cardboard, reconstituted tobacco paper, and cellophane. In some embodiments, the inhaler body is made of cellulosic material, such as paper, any other paper-based material, any other cellulose-based material, or a bioplastic-based material. Preferably the inhaler body is made from a biodegradable material. In a preferred embodiment, the inhaler body is made of paper or cardboard. The paper-based material may be bleached or unbleached. Paper-based materials may be one or more of light, cheap, and biodegradable. Preferably, the inhaler body exhibits sufficient mechanical strength and stiffness to withstand significant deformation during interaction with the receptacle, including the insertion of the mouthpiece element into the inhaler body. The inhaler body may be formed from a paper sheet. The inhaler body may be cut from a continuous sheet of paper. The inhaler body may be rolled from a continuous sheet of paper. This may simplify manufacturing of the inhaler body and the mouthpiece element.
The inhaler body and the mouthpiece element may be formed from materials that are biodegradable. Most preferably, the inhaler body is formed from a paper-based material, such as paper, paperboard or cardboard, and the mouthpiece element is formed from bioplastic, such as injection molded bioplastic.
The mouthpiece element may be designed to exhibit a desired resistance to draw (“RTD”). The RTD of a specimen refers to the static pressure difference between the two ends of the specimen when it is traversed by an air flow under steady conditions in which the volumetric flow is 17.5 milliliters per second at the output end. The RTD of a specimen may be measured using the method set out in ISO Standard 6565:2002. The mouthpiece element may have an RTD ranging from 30 to 200 mmWG. The mouthpiece airflow channel may be constructed to have any suitable dimensions to achieve a desired RTD. For example, the discharge portion of the airflow channel may have a cross sectional area of 2 mm2 to 15 mm2 or from 3 mm2 to 13 mm2.
The inhaler article may further comprise a wrapper wrapped about at least a portion of the inhaler body. The wrapper may also be wrapped about at least a portion of the mouthpiece element. In some embodiments, the wrapper does not cover the entire length of the mouthpiece element such that a portion of the length of the mouthpiece element is left uncovered. The wrapper may be a paper wrapper, such as a cigarette wrapper or tipping paper. The wrapper may be adhered by an adhesive.
According to an embodiment, the distal end of the mouthpiece element is inserted into or disposed inside the inhaler body. In some cases, the entire mouthpiece element may be inserted into or disposed inside the inhaler body. In some embodiments, the mouthpiece element comprises a tubular side wall extending from the proximal end of the mouthpiece to the distal end of the mouthpiece. The mouthpiece element may comprise an inner tube that forms a portion of the airflow channel. The tubular side wall may circumscribe the inner tube. The tubular side wall may be substantially straight, extending linearly along the length of the mouthpiece element. The mouthpiece element may have an outer diameter that is slightly smaller than the inner diameter of the inhaler body such that the mouthpiece element may be completely disposed inside the inhaler body. The proximal end of the mouthpiece element may be aligned with a proximal end of the inhaler body.
The mouthpiece element may comprise a blocker that is in the shape of a cylinder. The cylindrical blocker may be coaxial with the longitudinal center axis of the mouthpiece element. The mouthpiece element may further comprise a plurality of brackets extending from the blocker to the side wall of the mouthpiece element. The plurality of brackets may be arranged to maintain the blocker in place inside the side wall. The plurality of brackets may be arranged symmetrically about the blocker.
The inner tube may extend coaxially within the tubular side wall. The inner tube may form the proximal-most portion of the airflow channel. Thus, the discharge portion of the airflow channel may extend through the inner tube. The inner tube and therefore the discharge portion may extend along the longitudinal center axis. The blocker may be disposed at the distal end of the mouthpiece and may have a diameter that is equal to or greater than the inside diameter of the inner tube. The blocker and the inner tube may be coaxial. The blocker and the inner tube may be arranged such that a gap is left between the blocker and the inner tube. The gap may have an axial distance or length of 1 mm to 5 mm, or from 1.5 mm to 3 mm. The length of the gap (shown as L224 in
The off-set portion of the airflow channel may be arranged around the blocker. The off-set portion of the airflow channel may be formed of a plurality of channels disposed about the blocker. The plurality of channels may be symmetrically disposed about the blocker. The blocker may be held in place by brackets extending from the blocker to the tubular side wall of the mouthpiece element.
The collector surface may form a ring surrounding the inner tube. In some cases, the collector surface extends from the inner tube to the tubular side wall of the mouthpiece element. The collector surface may have any suitable shape. Preferably, the collector surface is shaped to enable capture of loose particles and return of the collected or captured particles to the receptacle. In some embodiments, the collector surface comprises a curved cross sectional shape in a cross section taken along the longitudinal center axis of the mouthpiece element. Preferably, the curved cross sectional shape is concave toward the distal end of the mouthpiece element.
The collector surface may be disposed proximally of the blocker. The collector surface may be disposed proximally of the gap between the blocker and the inner tube. At least a portion of the inner tube may extend from the collector surface toward the distal end of the mouthpiece element. The portion of the inner tube extending distally from the collector surface may have a length of 2 mm to 6 mm.
The mouthpiece airflow channel may be constructed to have any suitable dimensions to achieve a desired RTD. At the distal end, the available open area for airflow is limited by the size of the blocker. The inner diameter of the tubular side wall may be about 5 mm to about 8 mm. The blocker may have a diameter of 1.5 mm to 4 mm, or from 2 mm to 3 mm. At the proximal end, the available area for airflow is determined by the size of the discharge portion. The discharge portion of the airflow channel may have a cross sectional area of 10 mm2 to 20 mm2 or from 11 mm2 to 14 mm2. The mouthpiece element may exhibit an RTD of 30 mmWG or greater, 35 mmWG or greater, or 40 mmWG or greater. The RTD may be 75 mmWG or less, 60 mmWG or less, or 50 mmWG or less. For example, the RTD may be from 30 to 75 mmWG, preferably from 35 to 60 mmWG, more preferably from 40 to 50 mmWG. In one embodiment, the RTD is about 45 mmWG.
According to an embodiment, the distal end of the mouthpiece element is inserted into or disposed inside the inhaler body. In some cases, only a distal portion of the mouthpiece element is inserted into or disposed inside the inhaler body. That is, the mouthpiece element is only partially inserted inside the inhaler body. In some embodiments, the mouthpiece element comprises a recessed portion having a cross-sectional dimension (for example, diameter) that is smaller than the cross-sectional dimension (for example, diameter) of the blocker. The distal end portion of the mouthpiece element may be the blocker. The recessed portion may comprise a groove circumscribing the mouthpiece element. The recessed portion may define the collector surface. The recessed portion may comprise a plurality of airflow channel openings. The mouthpiece element may be inserted into the inhaler body such that at least the blocker and the recessed portion are disposed inside the inhaler body.
In some embodiments, the off-set portion of the airflow channel is formed between the tubular side wall of the inhaler body and a distal end portion of the mouthpiece element. The off-set portion of the airflow channel may extend from the receptacle to the recessed portion. The distal end portion of the mouthpiece element (for example, the blocker) may be disposed inside the inhaler body. The off-set portion of the airflow channel may be formed between the tubular side wall of the inhaler body and the blocker.
The airflow channel may further comprise an intermediate portion comprising at least one intermediate channel extending from at least one airflow channel opening to the discharge portion. The airflow channel may comprise a plurality of intermediate channels extending from the plurality of airflow channel openings to the discharge portion. The airflow channel may comprise one intermediate channel. The airflow channel may comprise two intermediate channels. The airflow channel may comprise three intermediate channels. The airflow channel may comprise four intermediate channels. In a preferred embodiment, the airflow channel comprises four intermediate channels. The plurality of intermediate channels are in fluid communication with the off-set portion and the discharge portion, connecting the two portions of the airflow channel. The plurality of intermediate channels may extend radially inward from the recessed portion. The plurality of channels may be orthogonal to the tube. The plurality of intermediate channels may be orthogonal to the discharge portion. The plurality of intermediate channels may be distributed symmetrically about the longitudinal center axis.
The mouthpiece element may comprise a molded shape. Preferably, the mouthpiece element comprises a cylindrical tube. The recessed portion may comprise a groove circumscribing the cylindrical tube. The mouthpiece element may comprise multiple sections or portions having varying cross sectional dimensions (for example, diameters). For example, the mouthpiece element may comprise a first reduced portion separating the mouth end disposed at the proximal end of the mouthpiece element from a main portion of the mouthpiece element. The first reduced portion may have a cross sectional dimension (for example, diameter) that is smaller than the cross sectional dimension (for example, diameter) of the mouth end and the cross sectional dimension (for example, diameter) of the main portion. The mouthpiece element may further comprise a second reduced portion between the main portion of the mouthpiece element and the recessed portion. The second reduced portion may have a cross sectional dimension that is smaller than a cross sectional dimension of the main portion and greater than the cross sectional dimension of the recessed portion. The difference in the dimensions of the second reduced portion and the main portion may be only slight. The difference in the dimensions of the second reduced portion and the main portion may account for the thickness of the tubular wall of the inhaler body such that when assembled, the inhaler wall appears to continue at about the same circumference from the inhaler body to the mouthpiece element. The difference in the dimensions of the second reduced portion and the main portion may be equal to the thickness of the tubular wall of the inhaler body.
The inhaler article may further comprise a wrapper. The transition from the inhaler body to the mouthpiece element may be covered by the wrapper. The wrapper may be wrapped about a portion of the mouthpiece element and at least a portion of the inhaler body. For example, the wrapper may extend distally from the main portion of the mouthpiece element. The first reduced portion and the mouth end of the mouthpiece element may be left uncovered by the wrapper. The wrapper may be a paper wrapper, such as a cigarette wrapper or tipping paper. The wrapper may be adhered by an adhesive.
The mouthpiece airflow channel may be constructed to have any suitable dimensions to achieve a desired RTD. The plurality of intermediate channels may have a combined cross sectional area of 10 mm2 to 20 mm2 or from 12 mm2 to 16 mm2. The discharge portion of the airflow channel may have a cross sectional area of 2 mm2 to 5 mm2 or from 3 mm2 to 4 mm2. The mouthpiece element may exhibit an RTD of 75 mmWG or greater, 100 mmWG or greater, or 120 mmWG or greater. The RTD may be 200 mmWG or less, 160 mmWG or less, or 140 mmWG or less. For example, the RTD may be from 75 to 200 mmWG, preferably from 100 to 160 mmWG, more preferably from 120 to 140 mmWG. In one embodiment, the RTD is about 130 mmWG.
The invention is defined in the claims. However, below there is provided a non-exhaustive list of non-limiting examples. Any one or more of the features of these examples may be combined with any one or more features of another example, embodiment, or aspect described herein.
Examples will now be further described with reference to the figures in which:
Schematic views of exemplary inhaler articles according to embodiments are shown in
The mouthpiece element 200, 300 is at least partially inserted into the inhaler body 100. The mouthpiece element 200, 300 has a proximal end 201, 301 and a distal end 202, 302. The distal end 202, 302 of the mouthpiece element 200, 300 is received in the interior of the inhaler body 100. As shown in
Referring now to
The inhaler article 10 may be used with a holder 400. The holder 400 may be configured to open the distal end 12 of the inhaler article 10. The holder 400 may be configured to provide an air inlet 401 for the inhaler article 10. The holder 400 may further be configured to pierce the capsule 15. An airflow pattern 410 flowing through the inhaler article 10 is schematically shown by the arrows in
A cross-sectional view and a perspective view of the mouthpiece element 200 are shown in
The mouthpiece element comprises a tube 240 extending coaxially with the inhaler body 100. The tube 240 comprises an interior surface 241 having an interior diameter D241. A blocker 230 is disposed at the distal end 202 of the mouthpiece element 200. The blocker 230 may be coaxial with the tube 240. The blocker 230 may be arranged to block airflow through the center of the mouthpiece element 200 at the distal end 202. The blocker 230 may be shaped as a cylinder. The blocker 230 has a diameter D230 that is equal to or greater than the interior diameter D241 of the tube 240. The mouthpiece element 200 may further comprise a plurality of brackets 233 extending from the blocker 230 to the side wall 203. The plurality of brackets 233 may be arranged to maintain the blocker 230 in place inside the mouthpiece element 200. The blocker 230 and the tube 240 may be arranged such that a gap 224 is left between the blocker 230 and the tube 240. The gap 224 has an axial length L224.
The space between the blocker 230 and the side wall 203, the gap 224, and the tube 240 together form an airflow channel 220 through the mouthpiece element 200. The space between the blocker 230 and the side wall 203 forms an off-set portion 221 of the airflow channel. The off-set portion 221 of the airflow channel 220 may be arranged around the blocker 230. The off-set portion 221 of the airflow channel 220 may be formed of a plurality of channels disposed about the blocker 230. The plurality of channels may be symmetrically disposed about the blocker.
The tube 240 forms the discharge portion 223 of the airflow channel 220, terminating at an outlet 211 at the proximal end 201 of the mouthpiece element 200. The gap 224 forms the intermediate portion 222 of the airflow channel, connecting the off-set portion 221 and the discharge portion 223.
The mouthpiece element 200 comprises a collector surface 250 comprising a ring 251. The ring 251 surrounds the tube 240 and is disposed proximal to the blocker 230. The ring 251 may be coaxial with the tube 240. The ring 251 may be coaxial with the blocker 230. The ring 251 defines an inner diameter D251 and an outer diameter D252.
The collector surface 250 may extend from the tube 240 to the side wall 203. The collector surface 250 may have any suitable shape. For example, the collector surface 250 may have a curved cross sectional shape in a cross section taken along the longitudinal center axis A of the mouthpiece element 200, as shown in
The length L224 of the gap 224 may be selected in view of the length L250 between a midpoint of the gap 224 and the proximal end of the collector surface 250. A longer length L250 may be coupled with a longer length L224 of the gap 224. A shorter length L250 may be coupled with a shorter length L224 of the gap 224.
The mouthpiece element 200 may have an outer diameter D200 that is slightly smaller than the inner diameter of the inhaler body 100 such that the mouthpiece element 200 may be completely disposed inside the inhaler body 100. The proximal end 201 of the mouthpiece element 200 may be aligned with a proximal end 11 of the inhaler body 10, as shown in
When a user uses the inhaler article 10, air with entrained dry powder particles may flow through the mouthpiece element 200 as shown schematically in
Referring now to
The inhaler article 10′ may be used with a holder 400. The holder 400 may be configured to open the distal end 12 of the inhaler article 10′. The holder 400 may be configured to provide an air inlet 401 for the inhaler article 10′. The holder 400 may further be configured to pierce the capsule 15. An airflow pattern 410′ flowing through the inhaler article 10′ is schematically shown by the arrows in
The inhaler article may further comprise a wrapper 13. The transition from the inhaler body 100 to the mouthpiece element 300 may be covered by the wrapper 13. The wrapper 13 may be wrapped about a portion of the mouthpiece element 300 and at least a portion of the inhaler body 100. For example, the wrapper 13 may extend distally from the main portion 344 of the mouthpiece element 300.
Cross-sectional views and a perspective view of the mouthpiece element 300 are shown in
The mouthpiece element comprises a tube 340 extending coaxially with the inhaler body 10′. The tube 340 comprises an interior surface 345 having an interior diameter D345. A blocker 330 is disposed at the distal end 302 of the mouthpiece element 300. The blocker 330 may be coaxial with the tube 340. The blocker 330 may be arranged to block airflow through the center of the mouthpiece element 300 at the distal end 302. The blocker 330 has a diameter D330 that is greater than the interior diameter D345 of the tube 340.
The mouthpiece element 300 comprises a recessed portion 351 having a cross-sectional dimension D351 that is smaller than the cross-sectional dimension D330 of the blocker 330. The recessed portion 351 may be formed by a groove circumscribing the mouthpiece element 300. The recessed portion 351 may comprise a plurality of airflow channel openings 312.
A transverse cross-sectional view of the mouthpiece element 300 at the recessed portion 351 is shown in
The space between the blocker 330 and the tubular side wall 101 of the inhaler body 100, the plurality of channels 353, and the tube 340 together form an airflow channel 320 through the mouthpiece element 300. The space between the blocker 330 and the tubular side wall 101 of the inhaler body 100 forms the off-set portion 321 of the airflow channel. The off-set portion 321 of the airflow channel 320 may be arranged around the blocker 330. The tube 340 forms the discharge portion 323 of the airflow channel 320, terminating in an outlet 311 at the proximal end 301 of the mouthpiece element 300. The plurality of channels 353 form the intermediate portion 322 of the airflow channel, connecting the off-set portion 321 and the discharge portion 323.
The mouthpiece element 300 comprises a collector surface 350 formed by the recessed portion 351. The collector surface 350 may be coaxial with the tube 340. The collector surface 350 may be coaxial with the blocker 330. The collector surface 350 may also be considered to include the recessed wall 352 between the airflow channel openings 312. The recessed portion 351 may form a collector region comprising the collector surface 350, where particles that are not drawn into or do not fall into the discharge portion 323 are collected. The collected particles may later be dislodged by turning the inhaler article upright (with the distal end 12 facing down) and dropped back into the receptacle. Alternatively, the inhaler article and mouthpiece may be cleaned by turning the inhaler article upside down and tapping the inhaler article against a surface (for example, a table). The inhaler article may be tapped several times to cause loose powder to fall out.
The collector surface 350 may extend from the inner diameter D351 to the side wall 101 of the inhaler body 100. The collector surface 350 is disposed proximally of the blocker 330. The collector surface 350 may be disposed distal to the tube 340. The collector surface 350 may have any suitable shape. For example, the collector surface 350 may have a curved cross sectional shape in a cross section taken along the longitudinal center axis A of the mouthpiece element 200, as shown in
The mouthpiece element 300 may comprise multiple sections or portions having varying cross sectional dimensions (for example, diameters). For example, the mouthpiece element 300 (for example, the tube 340) may comprise a first reduced portion 341 separating the mouth end 343 from a main portion 344 of the mouthpiece element 300. The first reduced portion 341 may have a cross sectional dimension D341 (for example, diameter) that is smaller than the cross sectional dimension D343 (for example, diameter) of the mouth end 343 and the cross sectional dimension D344 (for example, diameter) of the main portion 344. The mouthpiece element 300 may further comprise a second reduced portion 342 between the main portion 344 of the mouthpiece element and the recessed portion 351. The second reduced portion 342 may have a cross sectional dimension D342 that is smaller than the cross sectional dimension D344 of the main portion 344 and greater than the cross sectional dimension D351 of the recessed portion 351. The difference in the dimensions of the second reduced portion 342 and the main portion 344 may be only slight. The difference in the dimensions of the second reduced portion 342 and the main portion 344 may account for the thickness of the tubular wall 101 of the inhaler body such that the inhaler wall appears to continue at about the same circumference from the inhaler body 100 to the mouthpiece element 300, as shown in
When a user uses the inhaler article 10′, air with entrained dry powder particles may flow through the mouthpiece element 300 as shown schematically in
| Number | Date | Country | Kind |
|---|---|---|---|
| 20214434.1 | Dec 2020 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2021/061195 | 12/1/2021 | WO |
